Am J Transplant, Volume 5, Suppl 3 Archives - Page 69 of 170 - ATC Abstracts

2015 American Transplant Congress
Industry Payments to Transplant Surgeons
R. Ahmed, E. Chow, A. Massie, E. King, B. Orandi, S. Bae, L. Nicholas, B. Lonze, D. Segev.
Johns Hopkins, Baltimore.
The Open Payments Program (OPP) was implemented to publicly disclose industry payments to physicians, enabling patients to be aware of potential conflicts of interest. Outcomes…
2015 American Transplant Congress
Human CMV-Specific CD8 T Cells Exhibit Distinct Phenotypes and Distribution Patterns in Tissues and Circulation
C. Gordon,^1,2,5 J. Thome,^1,3 G. Tomer,¹ D. Farber.^1,3,4
¹Columbia Center for Translational Immunology, Columbia University Medical Center, New York; ²Medicine, Columbia University Medical Center, New York; ³Microbiology and Immunology, Columbia University Medical Center, New York; ⁴Surgery, Columbia University Medical Center, New York; ⁵University of Melborne, Melbourne, Australia.
IntroductionCMV persists and is controlled by T cells in multiple tissues; however, study of CMV responses has largely been limited to blood containing only 2-3%…
2015 American Transplant Congress
Screening for West Nile Virus in California: Resolving IgM Anti-WNV in the Area With Dengue Seroprevalence
C. Chinchilla-Reyes,^1,2 D. Tanglao,¹ T. Mone,³ M. Koss,¹ M. Nowicki.^1,2
¹Viracor-IBT Laboratories, Los Angeles; ²Mendez National Institute of Transplantation Foundation, Los Angeles; ³OneLegacy, Los Angeles.
West Nile Virus (WNV) symptoms develop 2-15 days after exposure with a short period of viremia (6-7 days). It is possible to detect WNV in…
2015 American Transplant Congress
Long-Term Metabolic Outcomes of Functioning Pancreas Transplants in Type 2 Diabetic Recipients
S. Shin, Y. Kim, B. Choi, J. Choi, J. Jung, H. Cho, D. Han.
Asan Medical Center, Seoul, Korea.
Background Limited data are available on long-term metabolic outcomes of functioning pancreas transplants in patients with type 2 diabetes mellitus (T2DM). The aim of this…
2015 American Transplant Congress
Donor Derived Transmission Events in 2014: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)
D. Kaul,¹ S. Covington,² S. Taranto,² M. Green,¹ C. Wolfe.¹
¹OPTN Ad Hoc Disease Transmission Advisory Committee, Richmond, VA; ²United Network for Organ Sharing, Richmond, VA.
Background: The OPTN DTAC, a multidisciplinary committee, evaluates potential donor derived transmission events (PDDTE), including infections (I) & malignancies (M), to assess for donor transmitted…
2015 American Transplant Congress
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of Graft Failure and Mortality Among Kidney Transplant Recipients
P. Clayton,^1,2,3 W. Lim,^1,4 S. Chadban.^1,2,3
¹Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia; ²Transplantation, Royal Prince Alfred Hospital, Sydney, Australia; ³Sydney Medical School, University of Sydney, Sydney, Australia; ⁴Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
Purpose: Graft loss and death are generally late events after kidney transplantation, and trials designed to assess the impact of interventions on these outcomes are…
2015 American Transplant Congress
Effective Long-Term Prophylaxis against De Novo Hepatitis B With Hepatitis B Vaccination in Pediatric Recipients of HbcAb-Positive Liver Grafts
S. Lee, J.-M. Kim, G.-S. Choi, C.-H. Kwon, J.-W. Joh, S.-K. Lee.
Department of Surgery, Samsung Medical Center, Seoul, Korea.
Background) Controversy still exists concerning the use of livers from hepatitis B surface antigen-negative (HBsAg-)/hepatitis B core antibody-positive (HBcAb+) donors for liver transplantation (LT). We…
2015 American Transplant Congress
Left Ventricular Assist Device–Associated Allosensitization — Clinical Implications
B.-S. Ko, C. Willis, S. Drakos, D. Hurst, A. Kfoury, G. Snow, J. Delgado, E. Hammond, C. Selzman, R. Alharethi, S. McKellar, J. Nativi-Nicolau, E. Gilbert, P. Revelo, D. Miller, B. Reid, J. Fang, D. Eckles, J. Stehlik.
U.T.A.H. Cardiac Transplant Program, Salt Lake City, UT.
Purpose: Allosensitization has been recognized as a prognostic marker of worse outcome after transplant. It is unclear, however, whether sensitization events that take place shortly…
2015 American Transplant Congress
Survival Benefit of ECD Transplantation After Ultra-Long Dialysis Exposure: Implications for Acceptance in the New KAS
C. Kennedy, J. Dong, T. Myint, C. Rose, O. Johnston, J. Gill, J. Gill.
Division of Nephrology, University of British Columbia, Vancouver, BC, Canada.
The survival benefit of ECD transplantation varies with the duration of pre-transplant dialysis exposure.We analyzed the survival benefit of ECD transplantation (Kidney Donor Profile Index…
2015 American Transplant Congress
Association Between Histological Abnormalities in Time-Zero Renal Biopsies and Post-Donation eGFR in Live Donors
L. Fahmy, A. Massie, B. Orandi, S. Bagnasco, J. Alejo, B. Boyarsky, S. Anjum, R. Montgomery, N. Dagher, D. Segev.
Johns Hopkins, Baltimore.
Time-zero biopsies (T0-RBx) of live-donor kidneys may reveal histological abnormalities at the time of organ recovery. The association between T0-RBx and subsequent kidney function in…